A transplant of CRISPR-edited liver cells could replace lifelong injections for hemophilia B patients | FierceBiotech

More CRISPR magic…

A Salk Institute team found transplanting liver cells into hemophilic mice restored their ability to form blood clots. The hope is that this one-and-done treatment could replace the frequent injections of clotting factors currently used to treat the inherited blood disorder.
— Read on www.fiercebiotech.com/research/a-liver-cell-transplant-could-replace-lifelong-injections-for-hemophilia-b-patients

Leave a Reply

Your email address will not be published. Required fields are marked *